Louis Isaac Woolf
Canadian biochemist
Louis Isaac Woolf (1924–2012) was a prominent Canadian biochemist known for his pioneering research in the field of neurochemistry. His work significantly advanced the understanding of acetylcholinesterase and its inhibitors, contributing to the development of treatments for neurological disorders.
Early Life and Education[edit | edit source]
Louis Isaac Woolf was born in Montreal, Quebec, in 1924. He pursued his undergraduate studies at McGill University, where he developed a keen interest in chemistry and biochemistry. Woolf continued his education at the same institution, earning a Ph.D. in biochemistry in the early 1950s.
Career[edit | edit source]
Woolf began his career as a researcher at the Montreal Neurological Institute, where he focused on the study of neurotransmitters and their role in the central nervous system. His research on acetylcholinesterase, an enzyme critical for the breakdown of the neurotransmitter acetylcholine, was groundbreaking. Woolf's work helped elucidate the mechanisms by which acetylcholinesterase inhibitors could be used to treat conditions such as Alzheimer's disease and myasthenia gravis.
Research Contributions[edit | edit source]
Woolf's research was instrumental in the development of drugs that target acetylcholinesterase. His studies provided insights into the enzyme's structure and function, paving the way for the synthesis of more effective and selective inhibitors. These inhibitors are now widely used in the treatment of Alzheimer's disease, where they help to alleviate symptoms by increasing the levels of acetylcholine in the brain.
Awards and Honors[edit | edit source]
Throughout his career, Woolf received numerous accolades for his contributions to biochemistry and neurochemistry. He was a fellow of the Royal Society of Canada and received several prestigious awards, including the Gairdner Foundation International Award for his work on enzyme inhibitors.
Legacy[edit | edit source]
Louis Isaac Woolf's legacy lives on through his extensive body of research and the many students and researchers he mentored throughout his career. His work continues to influence the field of neurochemistry and the development of treatments for neurological disorders.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
